Schedule 13G ownership disclosure
Ocular Therapeutix Inc
Common Stock, $0.0001 par value per share · CUSIP: 67576A100
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 12,913,420.00 · Class: 7.3%
- VHCP Co-Investment Holdings III, LLC
Shares: 12,913,420.00 · Class: 7.3%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 12,913,420.00 · Class: 7.3%
- VHCP Management III, LLC
Shares: 12,913,420.00 · Class: 7.3%
- VHCP Management EG, LLC
Shares: 12,913,420.00 · Class: 7.3%
- Nimish Shah
Shares: 12,913,420.00 · Class: 7.3%
- Bong Y. Koh
Shares: 12,913,420.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001738048-25-000020
- Form type
- SCHEDULE 13G/A
- Filer
- OCULAR THERAPEUTIX, INC
- CIK
- CIK 1393434
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership